10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Hindson Benjamin J.
Mar 25 17:21 ET
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Saxonov Serge
Mar 25 17:20 ET
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer McAnear Justin J.
Mar 25 17:20 ET
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Saxonov Serge
Mar 18 19:06 ET
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Saxonov Serge
Mar 6 16:16 ET
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Saxonov Serge
Feb 26 16:18 ET
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Hindson Benjamin J.
Feb 26 16:17 ET
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer McAnear Justin J.
Feb 26 16:16 ET
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Saxonov Serge
Feb 20 16:25 ET
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Saxonov Serge
Feb 13 18:21 ET
10x Genomics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(8.65%)
Feb 13 18:17 ET
10x Genomics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(16.252%),Abigail P. Johnson(16.252%)
Feb 9 08:40 ET
10x Genomics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(5.5%)
Jan 31 14:13 ET
10x Genomics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baillie Gifford & Co (Scottish partnership)(7.60%)
Jan 29 11:48 ET
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Saxonov Serge
Jan 18 00:00 ET
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Saxonov Serge
Dec 29, 2023 00:00 ET
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Hindson Benjamin J.
Dec 29, 2023 00:00 ET
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Saxonov Serge
Dec 18, 2023 17:43 ET
10x Genomics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Morgan Stanley(3.5%)
Dec 8, 2023 16:37 ET
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Chief Commercial Officer Wilbur James
Nov 27, 2023 18:18 ET
No Data
No Data